Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience

BACKGROUND: Nearly all patients with malignant glioma will have disease recurrence. Our purpose was to define the treatment toxicity and efficacy of concurrent bevazicumab (BVZ) with hypofractionated stereotactic radiosurgery (SRS) of relatively larger targets for patients with recurrent MG. METHODS...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neurooncol Pract
Glavni autori: Clark, Grant M., McDonald, Andrew M., Nabors, Louis B., Fathalla-Shaykh, Hassan, Han, Xiaosi, Willey, Christopher D., Markert, James M., Guthrie, Barton L., Bredel, Markus, Fiveash, John B.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4369713/
https://ncbi.nlm.nih.gov/pubmed/26034629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npu028
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items